Navigation Links
Global Non-Small Cell Lung Cancer Partnering 2010 to 2017
Date:2/22/2017

NEW YORK, Feb. 22, 2017 /PRNewswire/ -- Summary

Provides understanding and access to the non-small cell lung cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Read the full report: http://www.reportlinker.com/p03605668-summary/view-report.html

Description
The Global Non-Small Cell Lung Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

- Trends in partnering deals
- Top deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Read the full report: http://www.reportlinker.com/p03605668-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-non-small-cell-lung-cancer-partnering-2010-to-2017-300412187.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Arthroscopy Devices Market Expected to Reach $5,334 Million, Globally, by 2022
2. Global Psoriasis Drugs Market Outlook 2022 - Research and Markets
3. Radiology Information System Market Expected to Reach $941 Million by 2022, Globally - Allied Market Research
4. Global $2.1 Billion Clot Management Devices Market Analysis & Trends Report 2017: 2013-2015 & 2016-2025 - Research and Markets
5. Global Body Temperature Monitoring Devices Market 2016-2021: Focus on Developing Non Contact Thermometers - Research and Markets
6. Indivumeds Cancer Database Reaches a Global Scale Through Partnership With the National Cancer Tissue Biobank (NCTB), Indian Institute of Technology Madras, Chennai, India
7. Global Patient Monitoring Equipment Market 2017-2021
8. Mass Spectrometer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
9. Micro Guide Catheters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
10. Infusion Pump Market by Product, Application & End User - Global Forecast to 2021
11. Diabetic Shoes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... PALO ALTO, Calif. , June 9, 2017 /PRNewswire/ ... medical device company focused on the design, manufacture, sale ... updated the market on the progress of its commercial ... AeroForm is now available in more than one hundred ... country. AeroForm offers a needle-free alternative ...
(Date:6/8/2017)... MCKINNEY, Texas , June 8, 2017 ... Company"), a leading developer and manufacturer of ... industry, announced today that Cressey & Company ... investment firm, has completed a growth-focused investment ... acquired a majority ownership position from selling ...
(Date:6/5/2017)... June 5, 2017 The Cincinnati ... Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded a ... . Results are based on an employee survey ... health and workplace improvement. The survey measures several aspects of ... ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... June 20, 2017 , ... ... To understand their regulatory principles, the research team developed expressRNA, a web platform ... motif analyses. This reveals at nucleotide resolution the ‘RNA maps’, which demonstrate that ...
(Date:6/20/2017)... ... 2017 , ... Uniform Advantage (UA), a multi-channel retailer of medical ... create tailored looks and athleisure-inspired outfits. UA Flex fabric is breathable, wrinkle resistant and ... With trendy looks hitting the medical community, UA Flex is for the medical professional ...
(Date:6/20/2017)... ... June 20, 2017 , ... BrightStar Care Centerville/South ... re-accredited by the Joint Commission, which accredits and certifies nearly 21,000 healthcare organizations ... nationwide as a symbol of quality that reflects an organization’s commitment to meeting ...
(Date:6/20/2017)... MD (PRWEB) , ... June 20, 2017 , ... ... “joy of living” aboard the line’s latest all-inclusive boutique ship, S.S. Joie de ... she was built specifically for cruising France’s Seine River and designed small enough to ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water advocate Sharon ... Kleyne Hour Power of Water, Global Climate Change and Your Health on VoiceAmerica ... crisis and how it affects the human eyes. , According to Sharon ...
Breaking Medicine News(10 mins):